Goldman Sachs continues clean sweep in pharma M&A

Goldman Sachs, which revealed better-than-expected first quarter results on Monday, has made a clean sweep on mega US pharmaceutical deals after picking up its fourth multi-billion dollar mandate this year. Its mandate comes as pharmaceuticals megadeals continue to prop up an otherwise depressed market for mergers and acquisitions.

Express Scripts has signed a definitive agreement to buy WellPoint's NextRx subsidiaries for $4.7bn (€3.5bn) in cash and stock, according to a statement from the group. Goldman Sachs and Bank of America Merrill Lynch are advising WellPoint while Credit Suisse, JP Morgan and Citigroup are advising Express Scripts.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire